156 related articles for article (PubMed ID: 4710486)
1. Protection by immune spleen cells against challenge with Moloney sarcoma virus. Effect of stage of donor response.
Pollack S; Nelson K
Transplantation; 1973 May; 15(5):510-3. PubMed ID: 4710486
[No Abstract] [Full Text] [Related]
2. Cell-mediated immunity to Moloney sarcoma virus in mice. II. Analysis of antigenic specificities involved in T lymphocyte-mediated in vivo rejection of murine sarcoma virus-induced tumors.
Gorczynski RM; Knight RA
Eur J Immunol; 1975 Feb; 5(2):148-55. PubMed ID: 1086221
[TBL] [Abstract][Full Text] [Related]
3. Suppression of Moloney sarcoma virus immunity following sensitization with attenuated virus.
Wood GW
Cancer Res; 1976 Dec; 36(12):4552-7. PubMed ID: 1000500
[TBL] [Abstract][Full Text] [Related]
4. Effect of host sex and splenectomy on moloney virus-induced sarcomas.
Pollack SB
Int J Cancer; 1971 Sep; 8(2):264-71. PubMed ID: 5133849
[No Abstract] [Full Text] [Related]
5. Studies on immunity to autochthonous mouse tumors.
Hellström I; Hellström KE; Pierce GE; Fefer A
Transplant Proc; 1969 Mar; 1(1):90-4. PubMed ID: 5406848
[No Abstract] [Full Text] [Related]
6. Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors.
Biasi G; Saggin L; Dazzi F; De Rossi A; Collavo D
J Immunol; 1983 Mar; 130(3):1447-50. PubMed ID: 6185589
[TBL] [Abstract][Full Text] [Related]
7. Antigenic specificities of the cellular immune response of C57BL/6 mice to the Moloney leukemia/sarcoma virus complex.
Enjuanes L; Lee JC; Ihle JN
J Immunol; 1979 Feb; 122(2):665-74. PubMed ID: 84033
[No Abstract] [Full Text] [Related]
8. Enhancement of normal lymphocyte cytotoxicity by sera with high antibody titers against H-2 or virus-associated antigens.
Harada M; Pearson G; Pettigrew H; Redmon L; Orr T
Cancer Res; 1973 Nov; 33(11):2886-93. PubMed ID: 4583975
[No Abstract] [Full Text] [Related]
9. Protective effect of immune sera against transplantable Moloney virus-induced sarcoma and lymphoma.
Pearson GR; Redmon LW; Bass LR
Cancer Res; 1973 Jan; 33(1):171-8. PubMed ID: 4734119
[No Abstract] [Full Text] [Related]
10. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
[No Abstract] [Full Text] [Related]
11. [Humoral reactions in BALC/c mice with sarcomatous Moloney-induced tumor].
Yakimenko LV; Vetrova EP; Kaminskaya LP; Berdova AG; Umansky YA
Vopr Onkol; 1979; 25(9):46-50. PubMed ID: 573520
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Moloney murine lymphoma and sarcoma growth in vivo by dietary retinoids.
Dillehay DL; Shealy YF; Lamon EW
Cancer Res; 1989 Jan; 49(1):44-50. PubMed ID: 2783245
[TBL] [Abstract][Full Text] [Related]
13. The influence of alpha-fetoprotein on Moloney sarcoma virus oncogenesis: evidence for generation of antigen nonspecific suppressor T cells.
Gershwin ME; Castles JJ; Ahmed A; Makishima R
J Immunol; 1978 Dec; 121(6):2292-8. PubMed ID: 82580
[No Abstract] [Full Text] [Related]
14. In vivo elimination by specific effector cells of an established syngeneic rat moloney virus-induced sarcoma.
Fernandez-Cruz E; Halliburton B; Feldman JD
J Immunol; 1979 Oct; 123(4):1772-7. PubMed ID: 158055
[TBL] [Abstract][Full Text] [Related]
15. Cell-mediated reaction against tumors induced by oncornaviruses. I. Kinetics and specificity of the immune response in murine sarcoma virus (MSV)-induced tumors and transplanted lymphomas.
Leclerc JC; Gomard E; Levy JP
Int J Cancer; 1972 Nov; 10(3):589-601. PubMed ID: 4128690
[No Abstract] [Full Text] [Related]
16. Suppression of cell-mediated tumour immunity by Corynebacterium parvum.
Kirchner H; Glaser M; Herberman R
Nature; 1975 Oct; 257(5525):396-8. PubMed ID: 170531
[No Abstract] [Full Text] [Related]
17. Tumor immunity in vivo: evidence that immune destruction of tumor leaves "bystander" cells intact.
Weissman IL
J Natl Cancer Inst; 1973 Aug; 51(2):443-8. PubMed ID: 4765368
[No Abstract] [Full Text] [Related]
18. Further evidence for the involvement of thymus-processed lymphocytes in syngeneic tumor cell cytolysis.
Plata F; Gomard E; Leclerc JC; Levy JP
J Immunol; 1973 Sep; 111(3):667-71. PubMed ID: 4542607
[No Abstract] [Full Text] [Related]
19. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
McDonald TL
J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
[TBL] [Abstract][Full Text] [Related]
20. Immunity to murine sarcoma virus (MSV)-induced tumors demonstrated by "in vivo" elimination of 51-chromium labeled tumor cells.
Burstein NA
Rev Eur Etud Clin Biol; 1970 Oct; 15(8):873-5. PubMed ID: 4322224
[No Abstract] [Full Text] [Related]
[Next] [New Search]
